MDVIP
MDVIP is a Boca Raton, Florida-based company that operates a network of physicians. The company was founded in 2000 and has grown to include over 1,000 physicians serving more than 325,000 patients across the United States. MDVIP operates on a concierge medicine model, where patients pay an annual fee for enhanced healthcare services.
History[edit | edit source]
MDVIP was founded in 2000 by Dr. Edward Goldman, Dr. Robert Colton, and Dr. Robert Fields. The company was initially backed by Procter & Gamble, which purchased a majority stake in 2009. In 2014, Procter & Gamble sold MDVIP to Summit Partners, a private equity firm.
Services[edit | edit source]
MDVIP physicians provide a range of services, including preventive care, wellness programs, and personalized healthcare plans. The company's model emphasizes a strong doctor-patient relationship, with physicians limiting their practices to no more than 600 patients to ensure personalized care. Patients also have access to their physician 24/7 and can schedule same or next-day appointments.
Criticism[edit | edit source]
MDVIP has faced criticism for its business model, with critics arguing that it contributes to healthcare inequality by making high-quality care available only to those who can afford the annual fee. The company has also faced legal challenges, including a 2015 lawsuit in which a jury awarded $8.5 million to the family of a patient who died under the care of an MDVIP-affiliated physician.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
MDVIP Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD